Pharming (PHAR) Convertible Debt (2020 - 2026)
Pharming (PHAR) recorded Convertible Debt of $94.34 million in Q3 2026, up 1.3% from $93.14 million a year earlier and up 2.1% from the prior quarter.
Powered by 
Analysis
Pharming (PHAR) Convertible Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Pharming reported Convertible Debt of $92.72 million, up 18.6% from FY2024.
- Annual Convertible Debt has a five-year compound annual growth rate of -9.1% (FY2020 to FY2025).
- Across earlier years, Convertible Debt came in at $78.15 million in FY2024 (-42.8%), $136.6 million in FY2023 (+3.8%), $131.62 million in FY2022 (-5.3%) and $139.01 million in FY2021 (-7.2%).
- The Q3 2026 figure is the highest quarterly Convertible Debt since Q4 2023.
- On a year-over-year basis, Convertible Debt has increased for six consecutive quarters, with an average decline of 0.7% over the last seven quarters.
- Peak year-over-year performance for Convertible Debt in the last five years was growth of 18.6% in Q4 2025, against a decline of 99.9% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $92.4 million (Q2 2026), $93.39 million (Q1 2026) and $92.72 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Pharming | 898.85 Mn | 429.52 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 94.34 Mn |
| Jun 30, 2026 | 92.40 Mn |
| Mar 31, 2026 | 93.39 Mn |
| Dec 31, 2025 | 92.72 Mn |
| Sep 30, 2025 | 93.14 Mn |
| Jun 30, 2025 | 91.27 Mn |
| Mar 31, 2025 | 83.85 Mn |
| Dec 31, 2024 | 78.15 Mn |
| Sep 30, 2024 | 92.10 Mn |
| Jun 30, 2024 | 87.32 Mn |
| Dec 31, 2023 | 136.60 Mn |
| Sep 30, 2023 | 129.73 Mn |
| Jun 30, 2023 | 134.18 Mn |
| Mar 31, 2023 | 133.58 Mn |
| Dec 31, 2022 | 131.62 Mn |
| Sep 30, 2022 | 120,005.00 |
| Jun 30, 2022 | 128.24 Mn |
| Mar 31, 2022 | 135.56 Mn |
| Dec 31, 2021 | 138,896.94 |
| Sep 30, 2021 | 140.96 Mn |
API Access
Pharming Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();